Lonzo Ball Hasn't Retired, but the NBA Retired Him Long Ago

Lonzo Ball Hasn't Retired, but the NBA Retired Him Long Ago

Last weekend, amid a flood of preseason exhibition announcements, I came across a post from Lonzo Ball. He wrote briefly that he had not retired, that he was still waiting for a call. Social media reacted in two familiar ways: half sympathy for the former No. 2 pick of 2026, half skepticism about whether he could still play elite basketball.

When I read that post a third time, what made me pause was not the content but the tense of the verb. He wrote in the present tense. "Still waiting." As if two seasons had not been erased, as if the cartilage transplant surgery had never happened.

That was the moment I realized the real story was not the retirement rumor. The real story was a question nobody dares ask directly: Does the NBA still have room for a 28-year-old with a knee worn down to bone-on-bone?

I had followed Lonzo Ball since his early days at UCLA, when American media built the image of a generational passing guard with rare court vision. His father, LaVar Ball, declared his son would be greater than Stephen Curry. People laughed, but no one denied the real talent. Being the No. 2 pick in 2026 was not luck.

But there is a truth Vietnamese fans rarely notice: Lonzo Ball was never as good a shooter as the media image suggested. At UCLA, he shot 41% from three on a small sample. In the NBA, that number dropped to 30.5% in his rookie season with the Lakers. He improved over the years, peaking at 42.3% in the 2026-21 season with the New Orleans Pelicans — but that was a season of only 55 games.

Last season with the Cleveland Cavaliers was a different picture. 35 games. 4.6 points per game. 4.0 rebounds. 3.9 assists. And 27.2% from three-point range. These numbers need no commentary. They speak for themselves. For a guard expected to become a modern "3-and-D" player — shoot threes and defend — hitting 27.2% from deep means losing half the reason to exist on the court.

Worse, his knee prevents him from doing the other half. Lonzo Ball's medical file is one of the most frightening in the modern NBA. He underwent cartilage transplant surgery — a procedure that replaces joint cartilage with donor tissue. In sports medicine, this signals chronic joint damage that is nearly impossible to fully recover from.

I spent a month rewinding Ball's games from the 2026-21 season in New Orleans. A month of silently rewinding tape taught me more than a decade of loudly asserting. Three times I watched and rewatched his bursts of speed. Three times I took notes on his passing in tight spaces. I discovered that Lonzo Ball at his peak was not a three-point shooter. He was a playmaker — a guard who could see passing angles others could not.

But to do that, he needs a knee. Needs lateral movement. Needs the ability to change direction suddenly. Needs the ability to withstand the load of 82 games per season. Those are things no surgery can fully restore.

The Cleveland Cavaliers gave him a chance as a backup guard. It was a modest role for a former No. 2 pick, but it reflected reality. They needed backcourt depth, and Ball was a cheap option. But then the Cavaliers traded for James Harden. Instantly, Ball became expendable.

He was traded to the Utah Jazz, a team in the midst of a rebuild. For such a team, a former No. 2 pick with name recognition could be worth a try. But the Jazz waived him. They did not keep him, even on a minimum contract.

That is the clearest market signal. When a rebuilding team rejects a player at near-zero cost, the answer is no longer a tactical question. It is a medical one.

A month ago, I spoke with a former NBA scout working in China. We talked about guards with skill sets similar to Ball — good playmaking, decent defense, but lacking scoring ability. He said something that made me think: "The modern NBA has no room for guards who can only pass. You have to shoot. And you have to shoot after running 10 kilometers."

That is the harsh reality. Rajon Rondo was once a generational passing guard with limited three-point range. But Rondo never underwent cartilage transplant surgery. Rondo could defend, steal, and change the pace of a game with his mind. Ball has similar qualities, but his body will not let him use them consistently.

The NBA has changed in a way that makes players like Lonzo Ball obsolete. A decade ago, a playmaking guard with good defense could have a long career. Today, every guard must shoot threes. Floor spacing is everything. And a player hitting 27.2% from deep creates no spacing.

I rewatched Ball's tape from the 2026-21 season, when he shot 42.3% from three. What stood out was that he was not a pure shooter. He shot threes within the rhythm of the offense. He moved off the ball, created space for teammates, and received passes in favorable positions. That is a skill that requires confidence and fitness. Both have disappeared since the injury.

This is what teams are weighing. They are not just looking at 27.2%. They are looking at whether Ball can still move effectively off the ball. Whether he can still defend at high intensity. Whether he can endure 82 games. And the answer to those questions, based on his medical file, is uncertain.

The Ball family is a separate topic. LaVar Ball once claimed he could beat Michael Jordan one-on-one. He built the Big Baller Brand and turned three sons into media stars before they played a single NBA minute. Lonzo was the most talented of them.

But branding does not help when your knee is dead. Branding does not create floor spacing. Branding does not help you move laterally on defense. In the NBA, commercial value only matters when competitive value still exists.

The retirement rumor originated from a podcast where Ball discussed his career in the past tense. He said "I used to" many times. And social media drew conclusions. That is how rumors form — not from an official announcement, but from verb tense.

Ball responded. He said he had not retired. And I believe him. But I also believe the market does not need him.

I have defended players abandoned by the market before. In 2026, I declared war on the entire football world for an unknown young player — wait until I finish the story. But this time, I must be honest with myself: I am not sure Lonzo Ball still has value.

Now I place two opposing hypotheses on the scale.

Hypothesis one: The market is right. Ball is finished. His knee cannot withstand NBA intensity. The 27.2% three-point mark is not random variance but a mechanical consequence — a weakened knee destabilizes the jump shot base, causing the shot to lose accuracy. A guard who cannot shoot threes and cannot move laterally is a defensive liability on any team.

Hypothesis two: The market is making a collective mistake. Teams are evaluating Ball through the lens of the worst season of his career, rather than looking at the foundational skill set. 3.9 assists per game over 35 games on a team changing systems is not bad. 4.0 rebounds from a guard position shows game-reading ability remains. And if the problem is indeed the knee, then surgery and rehabilitation could change everything.

Here is the key point I want to emphasize: Lonzo Ball's value was never in scoring but in connecting. But the modern NBA has become ruthless toward players who can only connect and cannot shoot.

I have followed the wave of analysis about Ball in Chinese and Vietnamese fan communities. Most agree he should retire. But none of them can pinpoint exactly what changed. They just look at 27.2% and conclude.

Yet people remember the declaration of war. I want them to stay for the discoveries.

I tried to find games where Ball played well last season. There was a February game where he had 8 assists and 2 steals in 22 minutes. There was another with 5 rebounds and 4 assists in 18 minutes. Small numbers, but they show the connective skill set remains. The problem is he cannot sustain it over 82 games.

And that is the crux of the entire story. The NBA does not pay for moments. The NBA pays for consistency.

What market analysis overlooks is contract structure. Lonzo Ball does not need a rotation spot. He needs a non-guaranteed minimum contract — the kind a team can sign and waive without losing anything.

This is the type of deal contending teams typically use when they need depth mid-season. If a starting guard gets injured in January, a team like the Denver Nuggets or Boston Celtics could call Ball. Risk near zero. Cost near zero. And if Ball can play 15 minutes a game with playmaking ability, that is a bargain.

But there is one thing I cannot ignore: the silence of the market. There are no reports of Ball working out for any team. No reports of any team's interest. In a league where information leaks within hours, this silence is more concerning than any number.

I could be wrong. I have been wrong many times in my career. Three times I mispronounced Kylian Mbappe's name on national television, and it taught me that truth is not in what I shout but in what I am willing to spend time understanding.

So this time, I am not shouting. I am just placing a conscious bet: if Lonzo Ball is signed, it will not happen this summer. It will happen in January or February, when a contending team loses a backup guard to injury. And it will be a non-guaranteed minimum contract.

And if no call comes before March, then the answer to the original question is clear. Not because he does not want to play. But because his knee has already answered for him.